Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inflammatory and immune pathways refer broadly to a network of intracellular and intercellular signaling cascades that coordinate the body’s defense mechanisms in response to harm or infection. These pathways involve numerous classes of molecules including pro- and anti-inflammatory cytokines (e.g., IL-1, IL-6, TNF-α), their receptors (e.g., IL-1R, TLRs), intracellular signal transducers (e.g., NF-κB, JAK-STAT), and various cell types such as macrophages, lymphocytes, and endothelial cells[1][2][3][5]. These pathways regulate processes such as leukocyte recruitment, cell proliferation, death, and tissue repair. Dysregulation contributes to diseases including chronic inflammation, autoimmunity, cancer, and infectious disease. Therapeutic interventions usually target specific nodes within these pathways—such as individual cytokines or kinases—rather than the broad pathway grouping itself[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammatory and Immune Pathways.